Small ruminant renew rate understood? |
More studies needed |
Single serotype? |
Facilitates control |
Mild form? |
Not well known |
Carrier state? |
Facilitates control |
Wildlife reservoir? |
Facilitates control |
Effective vaccines? |
Nigeria 75/1 and Sungri vaccine |
Vaccines induce long-lived immunity? |
Facilitates control |
Vaccines are safe? |
Facilitates control |
Vaccines are affordable and accessible? |
Could be better produced at a large scale |
Thermostable vaccines? |
Technology available |
Quality-assurance systems in place? |
AU-PANVAC, as independent vaccines quality control is present in Africa, otherwise no, such quality control exist in Asia |
Marked vaccines/DIVA system? |
Desirable but not initially important in control programme |
Vaccine production SOPs readily available? |
Could be developed relatively easily |
Clear epidemiological understanding? |
Some deficiencies, research required: need not delay initiation of systematic control |
Vaccine presentation suitable/packaging/ |
Small dose vials required |
Robust, validated laboratory diagnostic tools for agent detection, and serology to support rapid diagnosis, surveillance and seromonitoring of vaccination? |
Further development required |
Pen-side rapid test available? |
To be validated; not affordable to poor farmers |
Laboratory networks to support technology transfer for diagnosis and surveillance? |
Existent in only a few regions |
World reference laboratories established and supported? |
Three PPR WRL exist: CIRAD (France), CAHEC (China), and The Pirbright Institute (UK) |
Vaccine delivery optimized? |
Use of CAHWs, and animal marking a challenge |